Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 213 entries
Sorted by: Best Match Show Resources per page
Thyroglossal duct pathology and mimics.

Insights into imaging

Patel S, Bhatt AA.
PMID: 30725193
Insights Imaging. 2019 Feb 06;10(1):12. doi: 10.1186/s13244-019-0694-x.

Congenital anterior neck masses comprise a rare group of lesions typically diagnosed in childhood. Most commonly, lesions are anomalies of the thyroglossal duct, namely the thyroglossal duct cyst, along with ectopic thyroid tissue. Although usually suspected based on clinical...

Cite
Patel S, Bhatt AA. Thyroglossal duct pathology and mimics. Insights Imaging. 2019;10(1):12doi: 10.1186/s13244-019-0694-x.
Patel, S., & Bhatt, A. A. (2019). Thyroglossal duct pathology and mimics. Insights into imaging, 10(1), 12. https://doi.org/10.1186/s13244-019-0694-x
Patel, Swapnil, and Bhatt, Alok A. "Thyroglossal duct pathology and mimics." Insights into imaging vol. 10,1 (2019): 12. doi: https://doi.org/10.1186/s13244-019-0694-x
Patel S, Bhatt AA. Thyroglossal duct pathology and mimics. Insights Imaging. 2019 Feb 06;10(1):12. doi: 10.1186/s13244-019-0694-x. PMID: 30725193; PMCID: PMC6365310.
Copy Download .nbib Format: NLM
Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria.

Journal of diabetes and metabolic disorders

Muhammad FY, Pedro LM, Suleiman HH, Uloko AE, Gezawa ID, Adenike E, Ramalan M, Iliyasu G.
PMID: 30918841
J Diabetes Metab Disord. 2018 Aug 04;17(2):93-99. doi: 10.1007/s40200-018-0344-8. eCollection 2018 Dec.

INTRODUCTION: Diabetic foot ulcer is a major complication of diabetes with a high economic cost of managing. Data from resource limited setting will bring to light how patients in these localities suffer financially in addition to poverty and lack...

Cite
Muhammad FY, Pedro LM, Suleiman HH, et al. Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria. J Diabetes Metab Disord. 2018;17(2):93-99doi: 10.1007/s40200-018-0344-8.
Muhammad, F. Y., Pedro, L. M., Suleiman, H. H., Uloko, A. E., Gezawa, I. D., Adenike, E., Ramalan, M., & Iliyasu, G. (2018). Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria. Journal of diabetes and metabolic disorders, 17(2), 93-99. https://doi.org/10.1007/s40200-018-0344-8
Muhammad, Fakhraddeen Yahya, et al. "Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria." Journal of diabetes and metabolic disorders vol. 17,2 (2018): 93-99. doi: https://doi.org/10.1007/s40200-018-0344-8
Muhammad FY, Pedro LM, Suleiman HH, Uloko AE, Gezawa ID, Adenike E, Ramalan M, Iliyasu G. Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria. J Diabetes Metab Disord. 2018 Aug 04;17(2):93-99. doi: 10.1007/s40200-018-0344-8. eCollection 2018 Dec. PMID: 30918841; PMCID: PMC6405375.
Copy Download .nbib Format: NLM
Brain tumour post-treatment imaging and treatment-related complications.

Insights into imaging

Kessler AT, Bhatt AA.
PMID: 30411280
Insights Imaging. 2018 Dec;9(6):1057-1075. doi: 10.1007/s13244-018-0661-y. Epub 2018 Nov 08.

PURPOSE: The imaging of primary and metastatic brain tumours is very complex and relies heavily on advanced magnetic resonance imaging (MRI). Utilisation of these advanced imaging techniques is essential in helping clinicians determine tumour response after initiation of treatment....

Cite
Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging. 2018;9(6):1057-1075doi: 10.1007/s13244-018-0661-y.
Kessler, A. T., & Bhatt, A. A. (2018). Brain tumour post-treatment imaging and treatment-related complications. Insights into imaging, 9(6), 1057-1075. https://doi.org/10.1007/s13244-018-0661-y
Kessler, Alexander T, and Bhatt, Alok A. "Brain tumour post-treatment imaging and treatment-related complications." Insights into imaging vol. 9,6 (2018): 1057-1075. doi: https://doi.org/10.1007/s13244-018-0661-y
Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging. 2018 Dec;9(6):1057-1075. doi: 10.1007/s13244-018-0661-y. Epub 2018 Nov 08. PMID: 30411280; PMCID: PMC6269328.
Copy Download .nbib Format: NLM
Reply to S. Boutayeb et al.

JCO oncology practice

Lou E, Beg MS, Bergsland E, Eng C, Khorana AA, Kopetz S, Lubner S, Saltz L, Shankaran V, Zafar SY.
PMID: 32574129
JCO Oncol Pract. 2020 Aug;16(8):525. doi: 10.1200/OP.20.00394. Epub 2020 Jun 23.

No abstract available.

Cite
Lou E, Beg MS, Bergsland E, et al. Reply to S. Boutayeb et al. JCO Oncol Pract. 2020;16(8):525doi: 10.1200/OP.20.00394.
Lou, E., Beg, M. S., Bergsland, E., Eng, C., Khorana, A. A., Kopetz, S., Lubner, S., Saltz, L., Shankaran, V., & Zafar, S. Y. (2020). Reply to S. Boutayeb et al. JCO oncology practice, 16(8), 525. https://doi.org/10.1200/OP.20.00394
Lou, Emil, et al. "Reply to S. Boutayeb et al." JCO oncology practice vol. 16,8 (2020): 525. doi: https://doi.org/10.1200/OP.20.00394
Lou E, Beg MS, Bergsland E, Eng C, Khorana AA, Kopetz S, Lubner S, Saltz L, Shankaran V, Zafar SY. Reply to S. Boutayeb et al. JCO Oncol Pract. 2020 Aug;16(8):525. doi: 10.1200/OP.20.00394. Epub 2020 Jun 23. PMID: 32574129.
Copy Download .nbib Format: NLM
Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions.

Insights into imaging

Mohajeri Moghaddam S, Bhatt AA.
PMID: 29949034
Insights Imaging. 2018 Aug;9(4):511-526. doi: 10.1007/s13244-018-0608-3. Epub 2018 Jun 12.

PURPOSE: Intramedullary spinal cord abnormalities are often challenging to diagnose. Spinal cord biopsy is a high-risk procedure with the potential to cause permanent neurological injury. Magnetic resonance imaging is the modality of choice for diagnosis and preoperative assessment of...

Cite
Mohajeri Moghaddam S, Bhatt AA. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights Imaging. 2018;9(4):511-526doi: 10.1007/s13244-018-0608-3.
Mohajeri Moghaddam, S., & Bhatt, A. A. (2018). Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights into imaging, 9(4), 511-526. https://doi.org/10.1007/s13244-018-0608-3
Mohajeri Moghaddam, Sarah, and Bhatt, Alok A. "Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions." Insights into imaging vol. 9,4 (2018): 511-526. doi: https://doi.org/10.1007/s13244-018-0608-3
Mohajeri Moghaddam S, Bhatt AA. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights Imaging. 2018 Aug;9(4):511-526. doi: 10.1007/s13244-018-0608-3. Epub 2018 Jun 12. PMID: 29949034; PMCID: PMC6108975.
Copy Download .nbib Format: NLM
Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Oman medical journal

Salawu F, Olokoba A.
PMID: 25829994
Oman Med J. 2015 Jan;30(1):3-10. doi: 10.5001/omj.2015.02.

This article looks at the issues of excessive daytime sleepiness and unintended sleep episodes in patients with Parkinson's disease (PD) and explores the reasons why patients might suffer from these symptoms, and what steps could be taken to manage...

Cite
Salawu F, Olokoba A. Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease. Oman Med J. 2015;30(1):3-10doi: 10.5001/omj.2015.02.
Salawu, F., & Olokoba, A. (2015). Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease. Oman medical journal, 30(1), 3-10. https://doi.org/10.5001/omj.2015.02
Salawu, Fatai, and Olokoba, Abdulfatai. "Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease." Oman medical journal vol. 30,1 (2015): 3-10. doi: https://doi.org/10.5001/omj.2015.02
Salawu F, Olokoba A. Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease. Oman Med J. 2015 Jan;30(1):3-10. doi: 10.5001/omj.2015.02. PMID: 25829994; PMCID: PMC4371466.
Copy Download .nbib Format: NLM
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review.

Research and practice in thrombosis and haemostasis

Samuelson Bannow BR, Lee AYY, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M.
PMID: 30349884
Res Pract Thromb Haemost. 2018 Jun 19;2(4):664-669. doi: 10.1002/rth2.12111. eCollection 2018 Oct.

BACKGROUND: The management of anticoagulation for cancer-associated thrombosis (CAT) in patients with thrombocytopenia is controversial. Whereas some studies suggest that administration of reduced-dose low-molecular-weight heparin (LMWH) or temporary discontinuation for moderate and severe thrombocytopenia may be a safe and...

Cite
Samuelson Bannow BR, Lee AYY, Khorana AA, et al. Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review. Res Pract Thromb Haemost. 2018;2(4):664-669doi: 10.1002/rth2.12111.
Samuelson Bannow, B. R., Lee, A. Y. Y., Khorana, A. A., Zwicker, J. I., Noble, S., Ay, C., & Carrier, M. (2018). Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review. Research and practice in thrombosis and haemostasis, 2(4), 664-669. https://doi.org/10.1002/rth2.12111
Samuelson Bannow, Bethany R, et al. "Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review." Research and practice in thrombosis and haemostasis vol. 2,4 (2018): 664-669. doi: https://doi.org/10.1002/rth2.12111
Samuelson Bannow BR, Lee AYY, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M. Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review. Res Pract Thromb Haemost. 2018 Jun 19;2(4):664-669. doi: 10.1002/rth2.12111. eCollection 2018 Oct. PMID: 30349884; PMCID: PMC6178713.
Copy Download .nbib Format: NLM
l-arginine Supplementation Increased Only Endothelium-Dependent Relaxation in Sprague-Dawley Rats Fed a High-Salt Diet by Enhancing Abdominal Aorta Endothelial Nitric Oxide Synthase Gene Expression.

Clinical Medicine Insights. Cardiology

Adejare A, Oloyo A, Anigbogu C, Jaja S.
PMID: 32063725
Clin Med Insights Cardiol. 2020 Jan 29;14:1179546820902843. doi: 10.1177/1179546820902843. eCollection 2020.

BACKGROUND: Abnormal vascular reactivity and reduced expression of endothelial nitric oxide synthase (OBJECTIVES: This study was designed to investigate the mechanism by which oral l-arginine supplementation modulates vascular reactivity and METHODS: Forty-eight weaned male Sprague-Dawley rats of weight range...

Cite
Adejare A, Oloyo A, Anigbogu C, et al. l-arginine Supplementation Increased Only Endothelium-Dependent Relaxation in Sprague-Dawley Rats Fed a High-Salt Diet by Enhancing Abdominal Aorta Endothelial Nitric Oxide Synthase Gene Expression. Clin Med Insights Cardiol. 2020;14:1179546820902843doi: 10.1177/1179546820902843.
Adejare, A., Oloyo, A., Anigbogu, C., & Jaja, S. (2020). l-arginine Supplementation Increased Only Endothelium-Dependent Relaxation in Sprague-Dawley Rats Fed a High-Salt Diet by Enhancing Abdominal Aorta Endothelial Nitric Oxide Synthase Gene Expression. Clinical Medicine Insights. Cardiology, 141179546820902843. https://doi.org/10.1177/1179546820902843
Adejare, Abdullahi, et al. "l-arginine Supplementation Increased Only Endothelium-Dependent Relaxation in Sprague-Dawley Rats Fed a High-Salt Diet by Enhancing Abdominal Aorta Endothelial Nitric Oxide Synthase Gene Expression." Clinical Medicine Insights. Cardiology vol. 14 (2020): 1179546820902843. doi: https://doi.org/10.1177/1179546820902843
Adejare A, Oloyo A, Anigbogu C, Jaja S. l-arginine Supplementation Increased Only Endothelium-Dependent Relaxation in Sprague-Dawley Rats Fed a High-Salt Diet by Enhancing Abdominal Aorta Endothelial Nitric Oxide Synthase Gene Expression. Clin Med Insights Cardiol. 2020 Jan 29;14:1179546820902843. doi: 10.1177/1179546820902843. eCollection 2020. PMID: 32063725; PMCID: PMC6990607.
Copy Download .nbib Format: NLM
Long term follow up after transorbital penetrating injury: A case report.

American journal of ophthalmology case reports

Vloka C, Vloka A, Rath T, Stefko S.
PMID: 32642597
Am J Ophthalmol Case Rep. 2020 Jun 24;19:100792. doi: 10.1016/j.ajoc.2020.100792. eCollection 2020 Sep.

PURPOSE: Traumatic brain injury is the leading cause of mortality and disability among young individuals. Unfortunately, there are few publications concerning long term follow up of patients with these types of injuries. We present a case of trans-orbital penetrating...

Cite
Vloka C, Vloka A, Rath T, et al. Long term follow up after transorbital penetrating injury: A case report. Am J Ophthalmol Case Rep. 2020;19:100792doi: 10.1016/j.ajoc.2020.100792.
Vloka, C., Vloka, A., Rath, T., & Stefko, S. (2020). Long term follow up after transorbital penetrating injury: A case report. American journal of ophthalmology case reports, 19100792. https://doi.org/10.1016/j.ajoc.2020.100792
Vloka, Caroline, et al. "Long term follow up after transorbital penetrating injury: A case report." American journal of ophthalmology case reports vol. 19 (2020): 100792. doi: https://doi.org/10.1016/j.ajoc.2020.100792
Vloka C, Vloka A, Rath T, Stefko S. Long term follow up after transorbital penetrating injury: A case report. Am J Ophthalmol Case Rep. 2020 Jun 24;19:100792. doi: 10.1016/j.ajoc.2020.100792. eCollection 2020 Sep. PMID: 32642597; PMCID: PMC7334582.
Copy Download .nbib Format: NLM
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L.
PMID: 31102253
Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17.

The past three decades have seen a quadruple rise in the number of people affected by diabetes mellitus worldwide, with the disease being the ninth major cause of mortality. Type 2 diabetes mellitus (T2DM) often remains undiagnosed for several...

Cite
Bajaj S, Das AK, Kalra S, et al. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019;10(4):1189-1204doi: 10.1007/s13300-019-0629-z.
Bajaj, S., Das, A. K., Kalra, S., Sahay, R., Saboo, B., Das, S., Shunmugavelu, M., Jacob, J., Priya, G., Khandelwal, D., Dutta, D., Chawla, M., Surana, V., Tiwaskar, M., Joshi, A., Shrestha, P. K., Bhattarai, J., Bhowmik, B., Latt, T. S., Aye, T. T., Vijayakumar, G., Baruah, M., Jawad, F., Unnikrishnan, A. G., Chowdhury, S., Pathan, M. F., Somasundaram, N., Sumanathilaka, M., Raza, A., Bahendeka, S. K., Coetzee, A., Ruder, S., Ramaiya, K., Lamptey, R., Bavuma, C., Shaikh, K., Uloko, A., Chaudhary, S., Abdela, A. A., Akanov, Z., Rodrìguez-Saldaña, J., Faradji, R., Tiago, A., Reja, A., & Czupryniak, L. (2019). BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(4), 1189-1204. https://doi.org/10.1007/s13300-019-0629-z
Bajaj, Sarita, et al. "BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,4 (2019): 1189-1204. doi: https://doi.org/10.1007/s13300-019-0629-z
Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17. PMID: 31102253; PMCID: PMC6612329.
Copy Download .nbib Format: NLM
Quality of life after refractive surgery: ReLEx SMILE vs Femto-LASIK.

Clinical ophthalmology (Auckland, N.Z.)

Klokova OA, Sakhnov SN, Geydenrikh MS, Damashauskas RO.
PMID: 30988598
Clin Ophthalmol. 2019 Mar 26;13:561-570. doi: 10.2147/OPTH.S170277. eCollection 2019.

PURPOSE: The safety and effectiveness of complex myopic astigmatism correction using ReLEx SMILE or Femto-LASIK techniques have been well established. The purpose of the current study is to compare quality of life (QoL) outcomes following ReLEx SMILE or Femto-LASIK...

Cite
Klokova OA, Sakhnov SN, Geydenrikh MS, et al. Quality of life after refractive surgery: ReLEx SMILE vs Femto-LASIK. Clin Ophthalmol. 2019;13:561-570doi: 10.2147/OPTH.S170277.
Klokova, O. A., Sakhnov, S. N., Geydenrikh, M. S., & Damashauskas, R. O. (2019). Quality of life after refractive surgery: ReLEx SMILE vs Femto-LASIK. Clinical ophthalmology (Auckland, N.Z.), 13561-570. https://doi.org/10.2147/OPTH.S170277
Klokova, Olga Aleksandrovna, et al. "Quality of life after refractive surgery: ReLEx SMILE vs Femto-LASIK." Clinical ophthalmology (Auckland, N.Z.) vol. 13 (2019): 561-570. doi: https://doi.org/10.2147/OPTH.S170277
Klokova OA, Sakhnov SN, Geydenrikh MS, Damashauskas RO. Quality of life after refractive surgery: ReLEx SMILE vs Femto-LASIK. Clin Ophthalmol. 2019 Mar 26;13:561-570. doi: 10.2147/OPTH.S170277. eCollection 2019. PMID: 30988598; PMCID: PMC6440445.
Copy Download .nbib Format: NLM
Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.

Kidney international reports

Cambier A, Rabant M, Peuchmaur M, Hertig A, Deschenes G, Couchoud C, Kolko A, Salomon R, Hogan J, Robert T.
PMID: 29988999
Kidney Int Rep. 2018 Mar 29;3(4):916-925. doi: 10.1016/j.ekir.2018.03.013. eCollection 2018 Jul.

INTRODUCTION: There is a need for treatment guidelines and prognostic factor identification in children with primary IgA nephropathy. We analyzed the causative effect of steroids and the applicability of the Oxford classification.METHODS: A total of 82 consecutive children (mean...

Cite
Cambier A, Rabant M, Peuchmaur M, et al. Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. Kidney Int Rep. 2018;3(4):916-925doi: 10.1016/j.ekir.2018.03.013.
Cambier, A., Rabant, M., Peuchmaur, M., Hertig, A., Deschenes, G., Couchoud, C., Kolko, A., Salomon, R., Hogan, J., & Robert, T. (2018). Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. Kidney international reports, 3(4), 916-925. https://doi.org/10.1016/j.ekir.2018.03.013
Cambier, Alexandra, et al. "Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features." Kidney international reports vol. 3,4 (2018): 916-925. doi: https://doi.org/10.1016/j.ekir.2018.03.013
Cambier A, Rabant M, Peuchmaur M, Hertig A, Deschenes G, Couchoud C, Kolko A, Salomon R, Hogan J, Robert T. Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. Kidney Int Rep. 2018 Mar 29;3(4):916-925. doi: 10.1016/j.ekir.2018.03.013. eCollection 2018 Jul. PMID: 29988999; PMCID: PMC6035143.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 213 entries